Fauci refuses Senate appearance after invoking Fifth Amendment more than 100 times in COVID probe

Former top federal health official Anthony Fauci has turned down an invitation to appear voluntarily before another Senate investigative body examining aspects of the national response to the COVID-19 outbreak. The decision was communicated through his legal representative in response to an outreach from the chair of the Senate Permanent Subcommittee on Investigations.

The attorney representing Fauci contended that requiring another appearance so soon after a prior contentious session would amount to improper political targeting and unnecessary personal degradation. This stance comes amid ongoing Republican-led efforts to scrutinize decisions made during the public health crisis, including questions surrounding vaccine development and overall government management of the emergency.

The refusal follows a recent vote by Republicans on the Senate Homeland Security and Governmental Affairs Committee to advance a contempt citation against Fauci. That action stemmed from his decision to invoke constitutional protections against self-incrimination over 100 times during testimony delivered in late July.

Committee leadership has indicated plans to forward the contempt matter directly to federal prosecutors in Washington, D.C., potentially skipping a broader chamber vote. Discussions around the legal merits of this approach continue, with emphasis placed on presenting arguments to the Department of Justice.

A central point of contention involves a pardon issued by the previous presidential administration prior to the end of its term. Critics of Fauci’s position maintain that this clemency eliminated any remaining threat of federal criminal exposure, thereby weakening the foundation for declining to answer questions under the Fifth Amendment. Legal counsel for Fauci has firmly rejected that interpretation.

For several years, one prominent senator has pursued inquiries into Fauci’s earlier responsibilities at the National Institute of Allergy and Infectious Diseases. These probes have included claims that certain research funding supported high-risk studies potentially connected to the origins of the virus in a laboratory setting overseas. Calls for accountability and possible legal consequences have been repeated throughout this process.

Separate parallel reviews have focused on vaccine safety and effectiveness as well as broader pandemic decision-making. Related materials already obtained by investigators include records from a personal mobile device used during the crisis and more than a thousand pages drawn from a private journal. Outreach continues regarding whether formal compulsory measures will be pursued next and how any such demands might be met.